Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY
LUCY研究的最终分析:奥拉帕尼在真实世界环境中治疗BRCA突变、HER2阴性转移性乳腺癌的临床疗效和安全性
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-023-07165-x
Balmaña, Judith; Fasching, Peter A; Couch, Fergus J; Delaloge, Suzette; Labidi-Galy, Intidhar; O'Shaughnessy, Joyce; Park, Yeon Hee; Eisen, Andrea F; You, Benoit; Bourgeois, Hughes; Gonçalves, Anthony; Kemp, Zoe; Swampillai, Angela; Jankowski, Tomasz; Sohn, Joo Hyuk; Poddubskaya, Elena; Mukhametshina, Guzel; Aksoy, Sercan; Timcheva, Constanta V; Park-Simon, Tjoung-Won; Antón-Torres, Antonio; John, Ellie; Baria, Katherine; Gibson, Isabel; Gelmon, Karen A